# A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B

> **NCT02600975** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 20 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** R21 with ASO1B

## Key facts

- **NCT ID:** NCT02600975
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-08
- **Primary completion:** 2017-01-19
- **Final completion:** 2017-01-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02600975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02600975, "A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02600975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*